- Home
- NOAH vs KURA Comparison
NOAH vs KURA Comparison
Compare NOAH & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NOAH | KURA |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 754.2M | 830.1M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | NOAH | KURA |
|---|---|---|
| Price | $11.45 | $8.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $10.75 | ★ $26.88 |
| AVG Volume (30 Days) | 111.4K | ★ 1.4M |
| Earning Date | 11-25-2025 | 02-25-2026 |
| Dividend Yield | ★ 5.10% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.93 | N/A |
| Revenue | ★ $355,222,638.00 | $104,029,000.00 |
| Revenue This Year | N/A | $109.64 |
| Revenue Next Year | $3.13 | $62.82 |
| P/E Ratio | $12.35 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.67 | $5.41 |
| 52 Week High | $12.84 | $12.49 |
Technical Indicators
Market Signals| Indicator | NOAH | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 65.07 | 40.65 |
| Support Level | $10.97 | $8.13 |
| Resistance Level | $11.36 | $9.43 |
| Average True Range (ATR) | 0.36 | 0.49 |
| MACD | 0.06 | -0.07 |
| Stochastic Oscillator | 81.63 | 36.42 |
Price Performance
Historical ComparisonAbout NOAH Noah Holdings Limited
Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.